RBP4, which is involved in retinol metabolism, has also been identified to be associated with numerous metabolic diseases, such as insulin resistance (IR), type 2 diabetes mellitus, obesity, and cardiovascular risk [9,10]. This evidence concerns the gene RBP4 and obesity due to melanocortin 4 receptor deficiency.